8-K: Ascend Wellness Holdings Reports Strong Q4 and Full Year 2023 Results, Revenue Up 28%

Sentiment:

Quarterly and Annual Results


Ascend Wellness Holdings (AWH) announced a 28% increase in full-year net revenue to $519 million and a 14% increase in adjusted EBITDA to $107 million for 2023, marking its first full year of positive cash from operations and free cash flow.

Better than expectedThe company's full-year net revenue increased by 28%, exceeding expectations.The company achieved its first full year of positive cash from operations and free cash flow, which is a significant improvement.The company's adjusted EBITDA increased by 14% for the full year, indicating improved profitability.

Summary

  • Ascend Wellness Holdings (AWH) reported its financial results for the fourth quarter and full year ended December 31, 2023.
  • The company's full-year net revenue reached $519 million, a 28% increase year-over-year.
  • Adjusted EBITDA for the full year was $107 million, a 14% increase year-over-year.
  • AWH achieved its first full year of positive cash from operations and positive free cash flow.
  • In Q4 2023, net revenue was $140 million, a 25% increase year-over-year, while adjusted EBITDA was $32 million, a 15% increase year-over-year.
  • The company ended Q4 2023 with $73 million in cash and cash equivalents.
  • AWH opened six new dispensaries in 2023 and acquired four in Maryland, expanding its presence to seven states.
  • The company also launched a Cannabis Outlet Model in eight of its dispensaries.
  • AWH sold over 165,000 pounds of wholesale product, more than doubling the previous year's sales.
  • The company launched three new brands: Royale, Tunnel Vision, and Common Goods.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue growth, improved profitability, and positive cash flow. While there are some challenges, the overall tone is optimistic and indicates a company on a positive trajectory.

Positives

  • AWH achieved significant revenue growth, with a 28% increase in full-year net revenue.
  • The company demonstrated improved profitability with a 14% increase in full-year adjusted EBITDA.
  • AWH generated positive cash from operations and free cash flow for the first full year since its founding.
  • The company expanded its retail footprint by opening six new dispensaries and acquiring four in Maryland.
  • AWH's wholesale business saw substantial growth, with sales more than doubling year-over-year.
  • The company successfully launched three new brands, diversifying its product offerings.
  • AWH's cash position remains strong with $73 million in cash and cash equivalents at the end of Q4 2023.
  • The company is seeing positive legislative progress in Ohio and Pennsylvania.

Negatives

  • The company experienced a net loss of $19.3 million in Q4 2023, compared to a net loss of $15.1 million in Q4 2022.
  • The adjusted EBITDA margin decreased by 243 basis points for the full year compared to the prior year.
  • Retail sales in Illinois declined, impacting overall revenue.
  • The company faced cultivation challenges in Franklin, New Jersey earlier in the year.
  • General and administrative expenses increased as a percentage of revenue in Q4 2023 due to timing of certain expense accruals and one-time employment related items.
  • The net loss for 2023 was $48.2 million, although this was an improvement from the $80.9 million loss in 2022.

Risks

  • The company faces risks related to regulatory approvals and changes in cannabis laws.
  • AWH is exposed to market competition, particularly in states with new recreational sales.
  • The company's financial performance could be impacted by cultivation challenges and operational issues.
  • AWH's ability to refinance its term loan due in August 2025 is subject to market conditions and investor sentiment.
  • The company's future performance is dependent on the successful execution of its strategic initiatives.

Future Outlook

The company anticipates positive changes in federal cannabis reform and expects the Ohio adult-use program to roll out in the coming quarters. AWH is also encouraged by the Governor of Pennsylvania's call for an adult-use bill. The company is in early stages of discussions to refinance its term loan due in August 2025.

Management Comments

  • Abner Kurtin, Executive Chairman, expressed excitement about the company's future prospects and anticipated positive changes in federal cannabis reform.
  • John Hartmann, Chief Executive Officer, highlighted the company's impressive financial success, with 2023 net revenue reaching $519 million, a 28% growth from the previous year.
  • Mark Cassebaum, Chief Financial Officer, stated that the company is pleased to have generated meaningful cash from operations and free cash flow for the quarter and for the full-year.

Industry Context

AWH's results reflect the ongoing growth and expansion of the cannabis industry, with increasing acceptance and legalization of adult-use cannabis in various states. The company's expansion into new markets and the launch of new brands are consistent with industry trends. The company is also benefiting from the growth of the wholesale market.

Comparison to Industry Standards

  • AWH's 28% revenue growth for the year is strong compared to some multi-state operators, but some competitors have seen higher growth rates in rapidly expanding markets.
  • The company's adjusted EBITDA margin of 20.5% for the full year is within the range of other established cannabis companies, but some have achieved higher margins through operational efficiencies.
  • The achievement of positive cash flow from operations and free cash flow is a significant milestone for AWH, as many cannabis companies are still struggling to achieve profitability.
  • Compared to companies like Curaleaf and Green Thumb Industries, AWH is smaller in terms of revenue, but it is showing strong growth in key markets.
  • The company's expansion into Maryland and the launch of the Cannabis Outlet Model are strategic moves to capture market share and improve profitability, similar to strategies employed by other multi-state operators.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficerNAJohn HartmannMay 2023New appointment
Chief Financial OfficerNAMark CassebaumLater in 2023New appointment
Chief of OperationsNAChris HolzerLater in 2023New appointment
Chief of StoresNARick WilkinsLater in 2023New appointment
Chief Legal Officer and Corporate SecretaryNADenise PedullaLater in 2023New appointment
Chief People OfficerNAMelissa FeckSubsequent to year-endNew appointment

Stakeholder Impact

  • Shareholders will likely view the strong revenue growth and positive cash flow as positive developments.
  • Employees may benefit from the company's growth and expansion.
  • Customers will have access to a wider range of products and dispensaries.
  • Suppliers may see increased demand for their products.
  • Creditors may view the company's improved financial performance as a positive sign.

Next Steps

  • The company will continue to focus on disciplined growth and investing in low-risk capex opportunities.
  • AWH is in early stages of discussions to refinance its term loan due in August 2025.
  • The company expects the Ohio adult-use program to roll out in the coming quarters.
  • AWH will continue to monitor and potentially capitalize on legislative progress in Pennsylvania.

Key Dates

DateDescription
December 31, 2023End of the fourth quarter and full year for which financial results are reported.
March 12, 2024Date of the press release announcing the financial results.

Keywords

cannabis, multi-state operator, AWH, Ascend Wellness Holdings, financial results, revenue, EBITDA, dispensaries, wholesale, cash flow, cannabis brands

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.